Increased brain transport and metabolism of acetate in hypoglycemia unawareness

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 9, 2013, Pages 3811-3820

  Gulanski, Barbara I ^a,c   De Feyter, Henk M ^a   Page, Kathleen A ^a   Belfort DeAguiar, Renata ^a   Mason, Graeme F ^a   Rothman, Douglas L ^a,b   Sherwin, Robert S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale University   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ADRENALIN; CARBON 13; GLUCAGON; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; LACTIC ACID;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BRAIN CORTEX; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STEADY STATE;

ACETIC ACID; ADOLESCENT; ADULT; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BRAIN; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PURE AUTONOMIC FAILURE;

EID: 84883731681     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1701     Document Type: Article

References (47)

1. Diabetes Complication and Control Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-Term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
3. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002;45:937-948.
4. Cryer PE. Banting Lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes. 1994;43:1378-1389.
5. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 type 1 diabetic patients. Diabet Med. 1991; 8:217-222.
6. Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-Associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest. 1993;91:819-828.
7. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008; 57:3169-3176.
8. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes. 2006;55:929-934.
9. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 2004;53:955-962.
10. Shen J, Rycyna RE, Rothman DL. Improvements on an in vivo automatic shimming method [FASTERMAP]. Magn Reson Med. 1997;38:834-839.
11. Shen J, Petersen KF, Behar KL, et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13CNMR. Proc Natl Acad Sci USA. 1999;96:8235-8240.
12. Mangia S, Tkac I, Gruetter R, et al. Sensitivity of single-voxel 1HMRS in investigating the metabolism of the activated human visual cortex at 7 T. Magn Reson Imaging. 2006;24:343-348.
13. Michaelis T, Merboldt KD, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993; 187:219-227.
14. Mason GF, Petersen KF, De Graaf RA, Shulman GI, Rothman DL. Measurements of the anaplerotic rate in the human cerebral cortex using 13C magnetic resonance spectroscopy and [1-13C] and [2- 13C] glucose. J Neurochem. 2007;100:73-86.
15. Lebon V, Petersen KF, Cline GW, et al. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J Neurosci. 2002;22: 1523-1531.
16. Boumezbeur F, Mason GF, De Graaf RA, et al. Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 2010;30: 211-221.
17. Mason GF, Petersen KF, De Graaf RA, et al. A comparison of (13)C NMR measurements of the rates of glutamine synthesis and the tricarboxylic acid cycle during oral and intravenous administration of [1-(13)C]glucose. Brain Res Brain Res Protoc. 2003;10:181-190.
18. Waniewski RA, Martin DL. Preferential utilization of acetate by astrocytes is attributable to transport. J Neurosci. 1998;18:5225-5233.
19. Muir D, Berl S, Clarke DD. Acetate and fluoroacetate as possible markers for glial metabolism in vivo. Brain Res. 1986;380:336-340.
20. King P, Kong MF, Parkin H, Macdonald IA, Barber C, Tattersall RB. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci. 1998;94: 157-163.
21. Boumezbeur F, Petersen KF, Cline GW, et al. The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy. J Neurosci. 2010;30:13983-13991.
22. Van Hall G, Stromstad M, Rasmussen P, et al. Blood lactate is an important energy source for the human brain. J Cereb Blood Flow Metab. 2009;29:1121-1129.
23. De Feyter HM, Mason GF, Shulman GI, Rothman DL, Petersen KF. Increased brain lactate concentrations without increased lactate oxidation during hypoglycemia in type 1 diabetic individuals [published online May 28, 2013]. Diabetes. doi:10.2337/db13-0313.
24. Herzog RI, Jiang L, Herman P, et al. Lactate preserves neuronal metabolism and function following antecedent recurrent hypoglycemia. J Clin Invest. 2013;123:1988-1998.
25. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab. 2001;27:1766-1791.
26. Halestrap AP, Meredith D. The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflüg Arch Eur J Physiol. 2004;447:619-628.
27. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science. 1999;283:496-497.
28. Rothman DL, De Feyter HM, De Graaf RA, Mason GF, Behar KL. 13CMRSstudies of neuroenergetics and neurotransmitter cycling in humans. NMR Biomed. 2011;24:943-957.
29. Hertz L. Intercellular metabolic compartmentation in the brain: past, present and future. Neurochem Int. 2004;45:285-296.
30. Van de Ven KCC, De Galan BE, Van der Graaf M, et al. Effect of acute hypoglycemia on human cerebral glucose metabolism measured by 13C magnetic resonance spectroscopy. Diabetes. 2011;60: 1467-1473.
31. Jiang L, Herzog RI, Mason GF, et al. Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo. Diabetes. 2009;58:1266-1274.
32. Lei H, Gruetter R. Effect of chronic hypoglycaemia on glucose concentration and glycogen content in rat brain: a localized 13C NMR study. J Neurochem. 2006;99:260-268.
33. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulindependent diabetes mellitus. N Engl J Med. 1995;333:1726-1731.
34. Pelligrino DA, LaManna JC, Duckrow RB, Bryan RM, Harik SI. Hyperglycemia and blood-brain barrier glucose transport. J Cereb Blood Flow Metab. 1992;12:887-899.
35. Van de Ven KCC, Tack CJ, Heerschap A, Van der Graaf M, De Galan BE. Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest. 2013;123(2):623-629.
36. Van de Ven KCC, Van der Graaf M, Tack CJ, Heerschap A, De Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012;61:1974-1977.
37. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia. J Neurosci Res. 2005;82:525-530.
38. Grill V, Gutniak M, Bjorkman O, et al. Cerebral blood flow and substrate utilization in insulin-Treated diabetic subjects. Am J Physiol. 990;258:E813-E820.
39. Segel SA, Fanelli CG, Dence CS, et al. Blood-To-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes. 2001;50:1911-1917.
40. Bingham EM, Dunn JT, Smith D, et al. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia. 2005;48: 2080-2089.
41. Choi I-Y, Seaquist ER, Gruetter R. Effect of hypoglycemia on brain glycogen metabolism in vivo. J Neurosci Res. 2003;72:25-32.
42. Oz G, Tesfaye N, Kumar A, Deelchand DK, Eberly LE, Seaquist ER. Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab. 2012;32:256-263.
43. Pellerin L, Bergersen LH, Halestrap AP, Pierre K. Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res. 2005;79:55-64.
44. BentourkiaM,Michel C, Ferriere G, et al. Evolution of brain glucose metabolism with age in epileptic infants, children and adolescents. Brain Dev. 1998;20:524-529.
45. Cunnane S, Nugent S, Roy M, et al. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition. 2011;27:3-20.
46. Smith JP, Drewes LR. Modulation of monocarboxylic acid transporter- 1 kinetic function by thecAMPsignaling pathway in rat brain endothelial cells. J Biol Chem. 2006;281:2053-2060.
47. Smith JP, Uhernik AL, Li L, Liu Z, Drewes LR. Regulation of Mct1 by cAMP-dependent internalization in rat brain endothelial cells. Brain Res. 2012;1480:1-11.